ACRV Acrivon Therapeutics Inc. Common Stock

USD 7.15 0.69 10.595514
Icon

Acrivon Therapeutics Inc. Common Stock (ACRV) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 7.15

+0.69 (+10.60)%

USD 0.15B

0.13M

USD 19.17(+168.07%)

N/A

Icon

ACRV

Acrivon Therapeutics Inc. Common Stock (USD)
COMMON STOCK | NSD
USD 7.15
0.00 0
Take a Tour

Acrivon Therapeutics Inc. Common Stock (ACRV) Stock Forecast

Show ratings and price targets of :
USD 19.17
(+168.07%)

Based on the Acrivon Therapeutics Inc. Common Stock stock forecast from 6 analysts, the average analyst target price for Acrivon Therapeutics Inc. Common Stock is USD 19.17 over the next 12 months. Acrivon Therapeutics Inc. Common Stock’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Acrivon Therapeutics Inc. Common Stock is Slightly Bearish, which is based on 3 positive signals and 5 negative signals. At the last closing, Acrivon Therapeutics Inc. Common Stock’s stock price was USD 7.15. Acrivon Therapeutics Inc. Common Stock’s stock price has changed by +12.95% over the past week, +59.96% over the past month and -46.64% over the last year.

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...